CD38 plays critical role in multiple myeloma progression
Dr. Wu highlights global disparities in leukemia mortality
Off-the-shelf CAR NK-cell therapy shows promise for relapsed or refractory AML
The future of leukemia care requires investing in people, not just science
Ching-Hon Pui, MD, on the global effort to treat pediatric leukemia

Join SOHO

Home
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Roundtable Discussions
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Leukemia News

Chronic Lymphocytic Leukemia Leukemia

Longer-term ALPINE results show ‘sustained PFS benefit’ with zanubrutinib for CLL/SLL

by SOHO Insider Editors
January 31, 2025
0 Comments

Acute Myeloid Leukemia Leukemia News

Bone marrow microenvironment boosts AML patients’ response to donor lymphocyte infusion

by SOHO Insider Editors
January 29, 2025
0 Comments

Cells of the body under a microscope. Research of stem cells. Cellular Therapy and Regeneration. 3D illustration

Acute Myeloid Leukemia Leukemia News

HCT improves LFS of elderly patients with AML in phase 3 study

by Leah Sherwood
January 24, 2025
0 Comments

Leukemia News Society Updates

Ask Dr. Kantarjian your leukemia questions

by Leah Sherwood
January 22, 2025
0 Comments

Chronic Myeloid Leukemia Leukemia

IND approved in Korea for CML treatment KF1601

by Leah Sherwood
January 20, 2025
0 Comments

Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes News

FDA grants fast track designation to LYT-200 in AML

by Leah Sherwood
January 17, 2025
0 Comments

Leukemia Myelodysplastic Syndromes

FDA approves imatinib oral solution to treat leukemia, other cancers

by Leah Sherwood
January 4, 2025
0 Comments

Leukemia

Pathways & Perspectives with Pia Raanani, MD

by Leah Sherwood
January 3, 2025
0 Comments

Acute Myeloid Leukemia Leukemia Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

by Leah Sherwood
January 3, 2025
0 Comments

Leukemia News

FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation

by sohonews
November 21, 2024
0 Comments

1
2
3
4

POPULAR NEWS

Leukemia , Lymphoma , Multiple Myeloma , Myelodysplastic Syndromes , Myeloproliferative Neoplasms , News , Society Updates

Abstract submissions now open for SOHO 2025

February 14, 2025

Acute Myeloid Leukemia , Leukemia , Myelodysplastic Syndromes

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

January 3, 2025

66th American Society of Hematology Annual Meeting & Exposition , Leukemia

Asciminib benefit-risk profile bests other TKIs in CML

December 10, 2024

Top Categories

Cellular Therapy

11

Leukemia

34

Lymphoma

33

Multiple Myeloma

27

Myelodysplastic Syndromes

11

Myeloproliferative Neoplasms

8

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Leukemia News

Longer-term ALPINE results show ‘sustained PFS benefit’ with zanubrutinib for CLL/SLL

Bone marrow microenvironment boosts AML patients’ response to donor lymphocyte infusion

HCT improves LFS of elderly patients with AML in phase 3 study

Ask Dr. Kantarjian your leukemia questions

IND approved in Korea for CML treatment KF1601

FDA grants fast track designation to LYT-200 in AML

FDA approves imatinib oral solution to treat leukemia, other cancers

Pathways & Perspectives with Pia Raanani, MD

NCI’s myeloMATCH pushes the envelope in myeloid leukemia care

FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Recent Posts

CD38 plays critical role in multiple myeloma progression

Dr. Wu highlights global disparities in leukemia mortality

Off-the-shelf CAR NK-cell therapy shows promise for relapsed or refractory AML

About Us

Categories

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Contact Info

Follow Us

Leukemia News

Cellular Therapy

Leukemia

Lymphoma

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms